127 related articles for article (PubMed ID: 12002730)
21. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
22. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Devillier P; Roche N; Faisy C
Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
Meltzer EO; Gillman SA
Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
[TBL] [Abstract][Full Text] [Related]
27. Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis.
Theunissen EL; van Kroonenburgh MJ; van Deursen JA; Blom-Coenjaerts C; Ramaekers JG
Psychopharmacology (Berl); 2006 Jul; 187(1):95-102. PubMed ID: 16767419
[TBL] [Abstract][Full Text] [Related]
28. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
30. Fexofenadine.
Markham A; Wagstaff AJ
Drugs; 1998 Feb; 55(2):269-74; discussion 275-6. PubMed ID: 9506246
[TBL] [Abstract][Full Text] [Related]
31. Central nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-.
Isomura T; Kono T; Hindmarch I; Kikuchi N; Murakami A; Inuzuka K; Kawana S
PLoS One; 2014; 9(12):e114336. PubMed ID: 25501360
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis.
Shintani T; Ohata C; Koga H; Ohyama B; Hamada T; Nakama T; Furumura M; Tsuruta D; Ishii N; Hashimoto T
Dermatol Ther; 2014; 27(3):135-9. PubMed ID: 24102897
[TBL] [Abstract][Full Text] [Related]
33. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
Milgrom H; Kittner B; Lanier R; Hampel FC
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):358-63. PubMed ID: 17941284
[TBL] [Abstract][Full Text] [Related]
34. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations.
Tanizaki H; Nakahigashi K; Miyachi Y; Kabashima K
J Dermatolog Treat; 2013 Dec; 24(6):477-80. PubMed ID: 23534896
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
Berger WE; Lumry WR; Meltzer EO; Pearlman DS
Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
[TBL] [Abstract][Full Text] [Related]
37. Review of fexofenadine in the treatment of chronic idiopathic urticaria.
Kawashima M; Harada S; Tango T
Int J Dermatol; 2002 Oct; 41(10):701-6. PubMed ID: 12390200
[TBL] [Abstract][Full Text] [Related]
38. Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties.
Kawauchi H; Yanai K; Wang DY; Itahashi K; Okubo K
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626077
[TBL] [Abstract][Full Text] [Related]
39. Stimulating effects of H1-antagonists.
Theunissen EL; Vermeeren A; Vuurman EF; Ramaekers JG
Curr Pharm Des; 2006; 12(20):2501-9. PubMed ID: 16842173
[TBL] [Abstract][Full Text] [Related]
40. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
